CORE MEDICAL SOLUTIONS LTDActive

Company number 07524772Private limited companyIncorporated 2011
⚠ Confirmation statement overdue. It was due on 24 Feb 2026.

Key figures

£836,161+6.6%
Net assets 2024/25
+12.7%
Average annual growth 2020/21–2024/25
0250 k500 k750 k1 m2020/212021/222022/232023/242024/25

Like most small UK companies, CORE MEDICAL SOLUTIONS LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0500 k1 m1.5 m2020/212021/222022/232023/242024/25
Filed accounts2020/21–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand—100—183,720271,343
Total assets768,122—876,0661,008,0821,059,683
Total liabilities247,934—192,122179,032184,220
Net assets / total equity518,178100682,033784,078836,161
Average number of employees5—5910

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: CORE MEDICAL SOLUTIONS LTD

Company

CORE MEDICAL SOLUTIONS LTD is a private limited company registered with Companies House under company number 07524772. It was incorporated on 10 Feb 2011. Its status is active. The registered office is in Great yarmouth (NR30). Its nature of business (SIC 2007) is other human health activities (86900).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files small company accounts (filleted). Net assets were £836,161, up 6.6% on the previous year. Cash at bank and in hand was £271,343. Total assets were £1,059,683 and total liabilities £184,220. The company had an average of 10 employees. Figures are available for 5 financial years (2020/21–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 24 Feb 2026.